March 5, 2011 -- Fosun Pharma plans a $913 million IPO on the Hong Kong Exchange; Shijiazhuang Xingbai Pharma received a PE investment of $18.3 million from Israel-based Infinity; Renhe Pharmacy announced a $140 million private placement to buy stakes in four companies; Mindray Medical will acquire a controlling stake in an infusion pump company; MediciNova will form a JV with Zhejiang Medicine to develop an asthma drug; China’s vaccine regulatory system met WHO standards, which will prequalify China’s vaccine makers for WHO vaccine programs; Thermo Fisher Scientific is building a new manufacturing facility in Suzhou; Life Technologies opened an Asia-Pacific distribution hub in Singapore; Poniard Pharma was granted SFDA approval to conduct two Phase III trials of a cancer drug; and Sinovac filed to begin clinical trials of a pneumococcal conjugate vaccine. More details….
Stock Symbols: (SHA: 600196) (SHE: 000650) (NYSE: MR) (NSDQ: MNOV) (JASDQ: 4875) (SHA: 600216) (NYSE: TMO) (NSDQ: LIFE) (NSDQ: PARD) (NSDQ: SVA)
